Skip to content

Newsroom

The Media Call for journalists on Q2 2024 financial results takes place on July 30, 2024

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration

captcha
| Press release
First Environmental Award in Renal Care Awarded by EDTNA / ERCA and Fresenius Medical Care
The first “Green Innovation Award” was awarded today by a joint initiative of European Dialysis and Transplant Nurses Association/European Renal Care Association (EDTNA/ERCA) and Fresenius Medical…
| Press release
Fresenius Medical Care Reports Second Quarter And Half Year 2013 Results
Second Quarter 2013 Key Figures: Net revenue $ 3,613 million + 5% Operating income (EBIT) $ 544 million - 8% Adjusted operating income (EBIT) $…
| Press release
Münchens Oberbürgermeister Christian Ude besucht Werk von Fresenius Medical Care in Schweinfurt
Diese Pressemitteilung existiert nur in deutscher Sprache. Der Oberbürgermeister der Stadt München und SPD-Kandidat für das Amt des bayerischen Ministerpräsidenten, Christian Ude, hat heute das Werk…
| Press release
High-Volume Hemodiafiltration Improves Patient Survival – The Key Message of Fresenius Medical Care at the 50th ERA-EDTA Congress
The Catalonian Online Hemodiafiltration Survival Study (ESHOL) published in February 2013 confirms Fresenius Medical Care’s conviction that every patient should be given the chance to benefit from…
| Press release
Fresenius Medical Care shareholders approve simplification of capital structure and 16th consecutive dividend increase
Fresenius Medical Care, the world’s largest provider of dialysis products and services, will simplify the company’s capital structure. At the annual general meeting in Frankfurt today, a large…
| Press release
Fresenius Medical Care Reports First Quarter 2013 Results And Confirms Guidance For Full Year 2013
First Quarter Key Figures: Net revenue $ 3,464 million + 7% Operating income (EBIT) $ 493 million - 2% Net income attributable to shareholders of…
| Press release
Fresenius Medical Care initiates share buy-back program and plans simplification of capital structure
The management board and the supervisory board of Fresenius Medical Care, the world’s largest provider of dialysis products and services, have approved a share buy-back program. Fresenius Medical Care…
| Press release
FDA warning letter on Dialyzer Product Documentation – no effects expected on company guidance for 2013
Fresenius Medical Care North America (FMCNA) announced today that it has received a warning letter from the Food and Drug Administration (FDA), asserting that the organization did not conduct adequate…
| Press release
Fresenius Medical Care Reports Strong Fourth Quarter And Full Year 2012 Results In Line With Guidance
Full Year 2012 Summary:  Reported Net revenue $ 13,800 million + 10% Operating income (EBIT) $ 2,219 million + 7% Net income attributable to…
| Press release
Fresenius Medical Care Announces Successful Completion of Legal Matters
Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, announced today that the United States government’s litigation against its United States…
| Press release
Fresenius Medical Care Announces Update on Dialysate Concentrate Products
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, announced today that on December 12, 2012, a group of…
| Press release
Fresenius Medical Care Announces Appointment of Chief Officer for Global Research and Development
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, announced today the appointment of Dr. Olaf Schermeier…
1 ... 20 21 22 ... 26
Related content

Do you have any questions? Contact us!

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.